Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
15
CIMA_AEMPS:14
NMPA:1
Drug Approvals
Rupatadine Fumarate Tablets
- Product Name
- 富马酸卢帕他定片
- Approval Number
- 国药准字HJ20200036
- Approval Date
- Aug 26, 2020
NMPA
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Noucor Health S.A.
- Target Recruit Count
- 26
- Registration Number
- NCT06736340
- Locations
- 🇵🇹
Centro Hospitalar De Vila Nova De Gaia Espinho, Gaia, Portugal
🇵🇹Hospital Pedro Hispano, Matosinhos, Portugal
🇵🇹BlueClinical Phase I, Porto, Portugal
Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Noucor Health S.A.
- Target Recruit Count
- 48
- Registration Number
- NCT06708520
- Locations
- 🇵🇹
Centro Hospitalar De Vila Nova De Gaia Espinho, Gaia, Portugal
🇵🇹Hospital Pedro Hispano, Matosinhos, Portugal
🇵🇹Blueclinical Investigacao E Desenvolvimento Em Saude Lda., Porto, Portugal
News
No news found